4.6 Article

Heme oxygenase-1 in neovascularisation: A diabetic perspective

Journal

THROMBOSIS AND HAEMOSTASIS
Volume 104, Issue 3, Pages 424-431

Publisher

GEORG THIEME VERLAG KG
DOI: 10.1160/TH09-12-0825

Keywords

Heme oxygenase-1; neovascularisation; diabetes; wound healing; endothelial progenitor cells

Funding

  1. European Union [POIG 01.02-00-109/09, 01.02-00-069/09, POIG.02.01.00-12-064/08, 02.02.00-00-014/08]
  2. Ministry of Science and Higher Education [N 301 08032/3156, N N301 314837, N301 460938]
  3. Wellcome Trust

Ask authors/readers for more resources

Neovascularisation is crucial both for physiological processes, like development, wound healing, tissue regeneration, hair growth or menstrual cycle, and for pathological states, such as tumour progression, retinopathy and psoriasis. Blood vessel formation is orchestrated by numerous pro-angiogenic and anti-angiogenic factors, acting together to keep tight rein on this complicated, desirable but also dangerous process. One of the proteins important for neovascularisation is heme oxygenase-1 (HO-1), an enzyme degrading heme. This review focuses on the role of HO-1 in angiogenesis and vasculogenesis, having a closer look at the significance of this system in diabetes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available